State Street Corp Biocryst Pharmaceuticals Inc Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Biocryst Pharmaceuticals Inc stock. As of the latest transaction made, State Street Corp holds 8,849,588 shares of BCRX stock, worth $67 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

8,849,588

Previous 9,346,799 5.32%

Holding current value

$67 Million

Previous $57.8 Million 16.43%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$6.41 - $8.69 $3.19 Million - $4.32 Million	-497,211 Reduced 5.32%	8,849,588 $67.3 Million
Q2 2024 Aug 14, 2024	SELL	$4.13 - $6.79 $33.6 Million - $55.2 Million	-8,130,545 Reduced 46.52%	9,346,799 $57.8 Million
Q1 2024 May 15, 2024	BUY	$4.89 - $7.65 $23 Million - $36 Million	4,700,341 Added 36.79%	17,477,344 $88.8 Million
Q4 2023 Feb 14, 2024	BUY	$4.98 - $6.77 $11.5 Million - $15.6 Million	2,310,625 Added 22.08%	12,777,003 $76.5 Million
Q3 2023 Nov 14, 2023	SELL	$6.71 - $7.92 $12.1 Million - $14.2 Million	-1,797,591 Reduced 14.66%	10,466,378 $74.1 Million
Q2 2023 Aug 14, 2023	BUY	$6.96 - $8.81 $6.09 Million - $7.7 Million	874,346 Added 7.68%	12,263,969 $86.3 Million
Q1 2023 May 15, 2023	BUY	$7.94 - $11.84 $2.09 Million - $3.11 Million	262,762 Added 2.36%	11,389,623 $95 Million
Q4 2022 Feb 14, 2023	BUY	$10.5 - $14.2 $18.1 Million - $24.5 Million	1,722,614 Added 18.32%	11,126,861 $128 Million
Q3 2022 Nov 15, 2022	SELL	$10.79 - $14.81 $17.3 Million - $23.7 Million	-1,600,556 Reduced 14.54%	9,404,247 $118 Million
Q2 2022 Aug 15, 2022	BUY	$7.89 - $17.88 $27.9 Million - $63.3 Million	3,542,051 Added 47.46%	11,004,803 $116 Million
Q1 2022 May 16, 2022	SELL	$11.56 - $19.76 $9.09 Million - $15.5 Million	-786,277 Reduced 9.53%	7,462,752 $121 Million
Q4 2021 Feb 14, 2022	BUY	$11.18 - $15.46 $12.8 Million - $17.7 Million	1,143,706 Added 16.1%	8,249,029 $114 Million
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $12.1 Million - $15 Million	852,551 Added 13.63%	7,105,323 $102 Million
Q2 2021 Aug 16, 2021	SELL	$9.5 - $17.24 $10 Million - $18.2 Million	-1,056,044 Reduced 14.45%	6,252,772 $98.9 Million
Q1 2021 May 17, 2021	SELL	$7.37 - $13.61 $27.6 Million - $51 Million	-3,748,163 Reduced 33.9%	7,308,816 $74.3 Million
Q4 2020 Feb 16, 2021	SELL	$3.37 - $8.61 $17.3 Million - $44.1 Million	-5,126,994 Reduced 31.68%	11,056,979 $82.4 Million
Q3 2020 Nov 10, 2020	BUY	$3.43 - $5.53 $2.08 Million - $3.35 Million	605,578 Added 3.89%	16,183,973 $55.6 Million
Q2 2020 Aug 14, 2020	BUY	$1.9 - $5.61 $18.7 Million - $55.2 Million	9,832,343 Added 171.11%	15,578,395 $74.2 Million
Q1 2020 May 11, 2020	BUY	$1.6 - $4.11 $9.19 Million - $23.6 Million	5,746,052 New	5,746,052 $11.5 Million

Others Institutions Holding BCRX

# of Institutions

278

Shares Held

172M

Call Options Held

625K

Put Options Held

739K

View Full List

About BIOCRYST PHARMACEUTICALS INC

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.41B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

More about BCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Biocryst Pharmaceuticals Inc Transaction History